DeepMind releases AlphaGenome 2 DNA model with doubled variant detection
The move from tissue-level averages to single-cell-type resolution changes what genetics labs can do with variant interpretation: rare-disease teams can now pinpoint which specific cell type a variant disrupts rather than relying on broad tissue signals. Computational biologists and genomics researchers can start testing it immediately via the free AlphaGenome API for non-commercial work. Compared with prior variant-effect predictors, the conditional architecture and cross-modal imputation reduce the need to run every assay before planning follow-up experiments.
IT之家Source